Rationale and results of correction of cognitive dysfunction in patients with chronic heart failure and a reduced left ventricular ejection fraction using a combination of meldonium and gamma-butyrobetaine
Journal Title: Серце і судини - Year 2018, Vol 0, Issue 4
Abstract
The aim — to evaluate the effect of the innovative combination of meltedonium and γ‑butyrobetaine (GBB) on the state of cognitive function, quality of life and endothelial function in patients with chronic heart failure (CHF) and reduced left ventricular ejection fraction (LV EF). Materials and methods. We examined 24 patients with stable CHF and reduced LV EF (< 40 %) of the II — III functional class according to NYHA not older than 75 years who had cognitive impairments identified using standardized testing. All patients underwent general clinical examination using standard methods of psychological testing (Mini‑Mental State Examination (MMSE), Schulte tests, HADS scale, Minnesota Living with Heart Failure Questionnaire (MLHFQ), self‑assessment by patients of household physical activity using the Duke University questionnaire), ultrasound diagnosis of the vasodilating function of the endothelium of the brachial artery (VDFE BA) using a test with reactive hyperemia. The combination of meldonium with GBB was administered in a dose of 2 capsules three times a day (every 8 hours) for 4 weeks. Results and discussion. After treatment with a combination of meldonium and GBB, we observed a statistically significant improvement in cognitive function indicators on the MMSE scale (p < 0.001), Schulte test (p < 0.001), as well as the quality of life by MLHFQ (p = 0.02). While taking the drug, a significant improvement of the endothelium‑dependent vasodilatory response was observed (p < 0.001). No statistically significant effect of the combination of meldonium and GBB on the level of anxiety (HADS‑A scale) and depression (HADS‑D) was observed. Conclusions. Administration to patients with CHF and decreased LV EF of a fixed combination of meldonium and GBB for 4 weeks in addition to standard basic treatment (angiotensin‑converting enzyme inhibitor, b‑blocker, mineralcorticoid receptor antagonist, diuretic) was associated with a statistically significant improvement in cognitive tests results (total score by MMSE, Schulte test run time), quality of life by MLHFQ and significant improvement in VDFE BA according to the test with reactive hyperemia.
Authors and Affiliations
L. G. Voronkov, A. S. Solonovych, A. V. Liashenko
Clinical and anatomical variants of varicose veins in the basin of small subcutaneous vein
The aim — to distinguish variants of the topography of the small subcutaneous vein (SSV) and its femoral branch (FB) according to the ultrasound scan, as well as to determine the pathways for the spread of venous reflux...
Tranexamic acid in intensive therapy of bleeding with different genesis
The problem of acute bleeding is relevant both in the medical and in the organizational aspects, and not only for Ukraine. The success of treatment is determined by a timely diagnosis and the speed of emergency medical c...
Prevention of cardiac events in perioperative period in patients with acute calculous cholecystitis and coronary heart disease
The aim — to evaluate the effectiveness of the advanced therapy for the prevention of cardiac complications in the pre, intra and early postoperative period in patients with acute calculous cholecystitis (ACC) and coro...
Vertebrobasilar infarctions: principles of classification, clinical and neuroimaging analysis and terminological definitions of the diagnosis
The aim — to describe the neurological clinic, specific symptoms and syndromes in patients with acute infarction of various anatomical and vascular territories of the posterior circular pool, to justify the use in clinic...
Vascular biomarkers: research methods, indicators, clinical, prognostic value and perspectives
The article deals with modern terminology, methods of studying of the rigidity of blood vessels, their diagnostic value. Taking into account the class and level of evidence, a modern understanding of the diagnostic signi...